




Searching News Database: anticoagulant
HSMN NewsFeed - 13 Sep 2022
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
HSMN NewsFeed - 15 Apr 2021
Valeo Pharma Announces Commercial Launch of Redesca(TM) and Redesca HP(TM)
Valeo Pharma Announces Commercial Launch of Redesca(TM) and Redesca HP(TM)
HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
HSMN NewsFeed - 9 Dec 2020
Valeo Pharma Announces Health Canada Approval for Redesca(TM) and Redesca Hp(TM)
Valeo Pharma Announces Health Canada Approval for Redesca(TM) and Redesca Hp(TM)
HSMN NewsFeed - 6 Mar 2019
Instrumentation Laboratory Receives US FDA Clearance For New Gem Premier Chemstat(TM) Testing System
Instrumentation Laboratory Receives US FDA Clearance For New Gem Premier Chemstat(TM) Testing System
HSMN NewsFeed - 9 Nov 2018
FDA authorizes emergency use of first Ebola fingerstick test with portable reader
FDA authorizes emergency use of first Ebola fingerstick test with portable reader
HSMN NewsFeed - 8 Aug 2018
United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint
United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint
HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
HSMN NewsFeed - 25 Aug 2016
Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin
Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
HSMN NewsFeed - 13 Nov 2015
AbbVie Submits IMBRUVICA(R) (ibrutinib) Phase III Combination Data to U.S. FDA
AbbVie Submits IMBRUVICA(R) (ibrutinib) Phase III Combination Data to U.S. FDA
HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
HSMN NewsFeed - 8 May 2015
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
HSMN NewsFeed - 2 Apr 2015
Perosphere Receives FDA Fast Track Designation for Investigational Anticoagulant Reversal Agent PER977
Perosphere Receives FDA Fast Track Designation for Investigational Anticoagulant Reversal Agent PER977
HSMN NewsFeed - 6 May 2014
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
HSMN NewsFeed - 13 Sep 2013
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
HSMN NewsFeed - 6 Aug 2012
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
HSMN NewsFeed - 18 Jul 2012
FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter from Crux Biomedical
FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter from Crux Biomedical
HSMN NewsFeed - 16 Mar 2012
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
HSMN NewsFeed - 16 Nov 2011
Boston Scientific's WATCHMAN(R) Device Implanted in First Patients in Latin America
Boston Scientific's WATCHMAN(R) Device Implanted in First Patients in Latin America
HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
HSMN NewsFeed - 16 Mar 2011
MAQUET Cardiovascular Receives European CE Mark for FUSION BIOLINE Vascular Graft
MAQUET Cardiovascular Receives European CE Mark for FUSION BIOLINE Vascular Graft
HSMN NewsFeed - 1 Dec 2010
Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex(R) for Fast Track Development
Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex(R) for Fast Track Development
HSMN NewsFeed - 17 Nov 2010
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
HSMN NewsFeed - 5 Oct 2010
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
HSMN NewsFeed - 25 Aug 2010
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
HSMN NewsFeed - 16 Jul 2010
Biomet Announces Acquisition of Substantially All of the Assets of Cytosol Laboratories, Inc.
Biomet Announces Acquisition of Substantially All of the Assets of Cytosol Laboratories, Inc.
HSMN NewsFeed - 16 Jun 2010
AGA Medical Enrolls First Patient in AMPLATZER(R) Cardiac Plug Clinical Trial
AGA Medical Enrolls First Patient in AMPLATZER(R) Cardiac Plug Clinical Trial
HSMN NewsFeed - 22 Sep 2009
FDA Clears Sysmex XE-2100D Hematology Analyzer for Blood Processing Center Quality Control Release Testing
FDA Clears Sysmex XE-2100D Hematology Analyzer for Blood Processing Center Quality Control Release Testing
HSMN NewsFeed - 24 Jun 2009
Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
HSMN NewsFeed - 8 Jun 2009
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
HSMN NewsFeed - 1 Apr 2009
Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
HSMN NewsFeed - 25 Feb 2009
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
HSMN NewsFeed - 3 Dec 2008
AGA Medical Receives European CE Mark Approval for AMPLATZER(R) Cardiac Plug
AGA Medical Receives European CE Mark Approval for AMPLATZER(R) Cardiac Plug
HSMN NewsFeed - 27 Oct 2008
St. Jude Medical Announces Publication of 20-Year Durability Data on Tissue Heart Valve
St. Jude Medical Announces Publication of 20-Year Durability Data on Tissue Heart Valve
HSMN NewsFeed - 24 Sep 2008
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
HSMN NewsFeed - 2 Sep 2008
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
HSMN NewsFeed - 21 Jul 2008
FDA Clears Osmetech's Warfarin Sensitivity Test and New eSensor(R) XT-8 Platform
FDA Clears Osmetech's Warfarin Sensitivity Test and New eSensor(R) XT-8 Platform
HSMN NewsFeed - 9 Jul 2008
Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
HSMN NewsFeed - 25 Jan 2008
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
HSMN NewsFeed - 13 Dec 2007
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
HSMN NewsFeed - 6 Dec 2007
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
HSMN NewsFeed - 8 Nov 2007
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
HSMN NewsFeed - 25 Oct 2007
Momenta Pharmaceuticals Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources
Momenta Pharmaceuticals Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources
HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
HSMN NewsFeed - 25 Sep 2007
Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
HSMN NewsFeed - 4 Sep 2007
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
HSMN NewsFeed - 22 Aug 2007
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
HSMN NewsFeed - 20 Aug 2007
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
HSMN NewsFeed - 26 Jun 2007
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
HSMN NewsFeed - 22 Jun 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
HSMN NewsFeed - 11 Jun 2007
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
HSMN NewsFeed - 4 Jun 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
HSMN NewsFeed - 31 Mar 2007
Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency
Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency
HSMN NewsFeed - 27 Mar 2007
United Therapeutics and Mochida Pharmaceutical Sign Remodulin Distribution Agreement for Japan
United Therapeutics and Mochida Pharmaceutical Sign Remodulin Distribution Agreement for Japan
HSMN NewsFeed - 26 Feb 2007
United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies
United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies
HSMN NewsFeed - 26 Dec 2006
Vascular Solutions Announces Approval of 'Pocket Protector' Indication for D-Stat Flowable Hemostat
Vascular Solutions Announces Approval of 'Pocket Protector' Indication for D-Stat Flowable Hemostat
HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
HSMN NewsFeed - 6 Jul 2006
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
HSMN NewsFeed - 29 Jun 2006
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
HSMN NewsFeed - 23 Jun 2006
Younger Patients Get New Options as Heart Specialists Revise Guidelines for Valve Procedures
Younger Patients Get New Options as Heart Specialists Revise Guidelines for Valve Procedures
Additional items found! 195

Members Archive contains
195 additional stories matching:
anticoagulant
(Password required)
anticoagulant
(Password required)